guhjy's aask [16 articles] Export

Recent papers added to guhjy's library classified by the tag aask. You can also see everyone's aask.

	Design and statistical aspects of the African American Study of Kidney Disease and Hypertension (AASK). [My Copy] Journal of the American Society of Nephrology : JASN, Vol. 14, No. 7 Suppl 2. (July 2003) by Jennifer J. Gassman, Tom Greene, Jackson T. Wright, et al.Lawrence Agodoa, George Bakris, Gerald J. Beck, Janice Douglas, Ken Jamerson, Julia Lewis, Michael Kutner, Otelio S. Randall, Shin-Ru R. Wang posted to stats rct gfr_formula aask by guhjy on 2009-10-10 08:19:46 as
	A Comparison of Iothalamate-GFR and Serum Creatinine-Based Outcomes: Acceleration in the Rate of GFR Decline in the African American Study of Kidney Disease and Hypertension [My Copy] J Am Soc Nephrol, Vol. 15, No. 12. (1 December 2004), pp. 3175-3183. by Julia Lewis, Tom Greene, Lawrence Appel, et al.Gabriel Contreras, Janice Douglas, Jim Lash, Robert Toto, Fredrick Van Lente, Xuelei Wang, Jackson T. Wright, for the AASK Study Group posted to gfr-slope gfr-formula gfr doubling creatinine bias aask by guhjy on 2009-10-10 05:15:35 as
	Creatinine clearance as a measure of GFR in screenees for the African-American Study of Kidney Disease and Hypertension pilot study. [My Copy] American journal of kidney diseases : the official journal of the National Kidney Foundation, Vol. 32, No. 1. (July 1998), pp. 32-42. by J. Coresh, R. D. Toto, K. A. Kirk, et al.P. K. Whelton, S. Massry, C. Jones, L. Agodoa, F. Van Lente posted to longitudinal gfr-slope gfr-formula bias aask by guhjy on 2009-10-10 05:12:29 as
	Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. [My Copy] JAMA : the journal of the American Medical Association, Vol. 288, No. 19. (20 November 2002), pp. 2421-2431. by J. T. Wright, G. Bakris, T. Greene, et al.L. Y. Agodoa, L. J. Appel, J. Charleston, D. Cheek, J. G. Douglas-Baltimore, J. Gassman, R. Glassock, L. Hebert, K. Jamerson, J. Lewis, R. A. Phillips, R. D. Toto, J. P. Middleton, S. G. Rostand, posted to gfr-slope aask bp cv gfr proteinuria rct by guhjy on 2009-01-17 07:22:32 as
	Cardiovascular outcomes in the African American Study of Kidney Disease and Hypertension (AASK) Trial. [My Copy] American journal of kidney diseases : the official journal of the National Kidney Foundation, Vol. 48, No. 5. (November 2006), pp. 739-751. by K. Norris, J. Bourgoigne, J. Gassman, et al.L. Hebert, J. Middleton, R. A. Phillips, O. Randall, S. Rostand, S. Sherer, R. D. Toto, J. T. Wright, X. Wang, T. Greene, L. J. Appel, J. Lewis, posted to aask acei ccb cv proteinuria rct by guhjy on 2009-01-17 07:20:31 as
	Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial. [My Copy] JAMA : the journal of the American Medical Association, Vol. 285, No. 21. (6 June 2001), pp. 2719-2728. by L. Y. Agodoa, L. Appel, G. L. Bakris, et al.G. Beck, J. Bourgoignie, J. P. Briggs, J. Charleston, D. Cheek, W. Cleveland, J. G. Douglas, M. Douglas, D. Dowie, M. Faulkner, A. Gabriel, J. Gassman, T. Greene, Y. Hall, L. Hebert, L. Hiremath, K. Jamerson, C. J. Johnson, J. Kopple, J. Kusek, J. Lash, J. Lea, J. B. Lewis, M. Lipkowitz, S. Massry, J. Middleton, E. R. Miller, K. Norris, D. O'Connor, A. Ojo, R. A. Phillips, V. Pogue, M. Rahman, O. S. Randall, S. Rostand, G. Schulman, W. Smith, D. Thornley-Brown, C. C. Tisher, R. D. Toto, J. T. Wright, S. Xu, posted to aask acei bp ccb ckd proteinuria rct by guhjy on 2009-01-13 15:15:00 as
	Calcium channel blockers and renal protection: insights from the latest clinical trials. [My Copy] Journal of the American Society of Nephrology : JASN, Vol. 16 Suppl 1 (March 2005) by J. Segura, J. A. García-Donaire, L. M. Ruilope posted to aask ccb ckd rct by guhjy on 2009-01-01 14:22:41 as
	Validation of creatinine-based estimates of GFR when evaluating risk factors in longitudinal studies of kidney disease. [My Copy] Journal of the American Society of Nephrology : JASN, Vol. 17, No. 10. (October 2006), pp. 2900-2909. by Xuelei Wang, Julia Lewis, Lawrence Appel, et al.DeAnna Cheek, Gabriel Contreras, Marquetta Faulkner, Harold Feldman, Jennifer Gassman, Janice Lea, Joel Kopple, Mohammed Sika, Robert Toto, Tom Greene posted to surrogate rct longitudinal gfr-slope gfr-formula creatinine ckd aask by guhjy on 2009-01-01 14:17:34 as
	RAAS blockade, renal failure, ESRD, and death among African Americans in the AASK Posttrial Cohort Study. [My Copy] Archives of internal medicine, Vol. 168, No. 21. (24 November 2008), pp. 2383-2384. by M. A. Onuigbo posted to aask acei arb ckd mortality rct by guhjy on 2008-12-06 07:00:50 as
	ERSD, heart disease and African-Americans with hypertensive nephrosclerosis [My Copy] posted to aask cv hd outcome by guhjy on 2008-11-08 08:54:16 as
	Baseline characteristics of participants in the African American Study of Kidney Disease and Hypertension (AASK) Clinical Trial and Cohort Study. [My Copy] American journal of kidney diseases : the official journal of the National Kidney Foundation, Vol. 50, No. 1. (July 2007) by M. Sika, J. Lewis, J. Douglas, et al.T. Erlinger, D. Dowie, M. Lipkowitz, J. Lash, D. Cornish-Zirker, G. Peterson, R. Toto, J. Kusek, L. Appel, C. Kendrick, J. Gassman, posted to aask rct by guhjy on 2008-11-08 03:31:13 as
	The rationale and design of the AASK cohort study. [My Copy] Journal of the American Society of Nephrology : JASN, Vol. 14, No. 7 Suppl 2. (July 2003) by L. J. Appel, J. Middleton, E. R. Miller, et al.M. Lipkowitz, K. Norris, L. Y. Agodoa, G. Bakris, J. G. Douglas, J. Charleston, J. Gassman, T. Greene, K. Jamerson, J. W. Kusek, J. A. Lewis, R. A. Phillips, S. G. Rostand, J. T. Wright posted to aask rct by guhjy on 2008-11-07 16:08:59 as
	The relationship between magnitude of proteinuria reduction and risk of end-stage renal disease: results of the African American study of kidney disease and hypertension. [My Copy] Archives of internal medicine, Vol. 165, No. 8. (25 April 2005), pp. 947-953. by Janice Lea, Tom Greene, Lee Hebert, et al.Michael Lipkowitz, Shaul Massry, John Middleton, Stephen G. Rostand, Edgar Miller, Winifred Smith, George L. Bakris posted to rct proteinuria hd ckd change bp aask by guhjy on 2008-10-29 07:19:25 as
	Long-term effects of renin-angiotensin system-blocking therapy and a low blood pressure goal on progression of hypertensive chronic kidney disease in African Americans. [My Copy] Archives of internal medicine, Vol. 168, No. 8. (28 April 2008), pp. 832-839. by L. J. Appel, J. T. Wright, T. Greene, et al.J. W. Kusek, J. B. Lewis, X. Wang, M. S. Lipkowitz, K. C. Norris, G. L. Bakris, M. Rahman, G. Contreras, S. G. Rostand, J. D. Kopple, F. B. Gabbai, G. I. Schulman, J. J. Gassman, J. Charleston, L. Y. Agodoa, posted to aask acei arb bp ckd outcome race rct by guhjy on 2008-10-21 10:35:50 as
	Angiotensin-converting enzyme gene polymorphism predicts the time-course of blood pressure response to angiotensin converting enzyme inhibition in the AASK trial. [My Copy] Journal of hypertension, Vol. 25, No. 10. (October 2007), pp. 2082-2092. by V. Bhatnagar, D. T. O'Connor, N. J. Schork, et al.R. M. Salem, C. M. Nievergelt, B. K. Rana, D. W. Smith, G. L. Bakris, J. P. Middleton, K. C. Norris, J. T. Wright, D. Cheek, L. Hiremath, G. Contreras, L. J. Appel, M. S. Lipkowitz posted to aask ace acei bp rct snp by guhjy on 2008-08-16 07:54:33 as
	Metabolic syndrome, proteinuria, and the risk of progressive CKD in hypertensive African Americans. [My Copy] American journal of kidney diseases : the official journal of the National Kidney Foundation, Vol. 51, No. 5. (May 2008), pp. 732-740. by J. Lea, D. Cheek, D. Thornley-Brown, et al.L. Appel, L. Agodoa, G. Contreras, J. Gassman, J. Lash, E. R. Miller, O. Randall, X. Wang, W. McClellan, posted to aask ckd irs proteinuria secondary-analysis by guhjy on 2008-04-29 03:56:34 as

Note: You may cite this page as: http://www.citeulike.org/user/guhjy/tag/aask

ckd	1740
rct	1202
dn	1081
dm	1015
cancer	1006
ma	972
cv	914
hd	860
tgfb	796
snp	763
bp	641
ros	581
meta-analysis	515
uae	499
stats	479
kidney	479
software	462
mouse	462
genetics	447
mirna	444
pt	418
proteomics	411
mortality	408
inflammation	365
fbl	362
rat	359
proteinuria	355
pcr	348
tw	345
gdl	331
acei	331
db	326
test	325
inhibitor	319
urine	315
arb	314
method	312
ms	310
irs	307
apoptosis	304
mc	302
hcv	300
age	299
akt	293
r	292
aging	290
biomarker	286
mtor	284
ppi	278
bias	277
bayes	275
aki	269
gwa	268
aii	265
hg	261
nutrition	255
rnai	248
emt	246
ub	239
p53	235
egfr	235
fibrosis	232
1	227
obesity	227
pi3k	226
cox	226
smad	223
pbmc	221
drug	213
metab	213
hcc	212
gn	208
hypoxia	204
s6k	200
herb	199
erk	198
albumin	189
lc	186
collagen	183
nfkb	180
longitudinal	179
hif	179
lmm	178
stz	177
gfr	174
ua	170
pubmed	170
epigenetics	169
p38	168
japan	165
bioinf	164
power	163
cea	163
gender	162
lead	160
rage	159
dna-damage	158
cadmium	158
ref	154
genomics	148
vitamin-d	148
stata	147
ctgf	144
network	143
liver	142
book	138
screening	137
company	137
rt	136
diet	134
seq	132
phosphorylation	131
pkc	128
protein	128
mt	127
cell-cycle	126
go	125
systems-biology	124
pathway	124
kinase	123
esrd	123
no	121
lipid	118
creatinine	115
statin	114
proliferation	107
insulin	107
mapk	106
senescence	106
podocyte	105
regression	103
fish	103
pd	102
cad	102
gfr-formula	102
case-control	102
imputation	101
multiplicity	100
imaging	99
observational	98
rx	97
cloning	96
plasmid	96
pediatric	95
p21	95
methylation	95
recurrent	94
sirt	93
tnf	92
blood	92
betel	91
nhanes	90
chf	90
stat	90
pparg	90
nox	90
website	89
src	88
toxicology	88
phenotype	88
anemia	87
diagnosis	87
cytokine	87
lr	86
immunity	86
uti	85
at1	84
hypertrophy	84
china	83
epo	82
ebm	81
p	81
nonp	81
ca	81
oat	81
cachexia	80
hapmap	80
environment	80
review	78
gout	78
primer	78
qms	77
autophagy	75
signaling	75
ko	75
gene-therapy	73
promoter	73
missing	73
lpd	72
stone	72
gene-list	72
eqtl	72
surrogate	72
mv	71
ace	71
p-value	71
egf	70
salt	70
phd	69
cox2	69
mgo	67
uncertainty	66
tin	66
hts	65
normalization	65
mirna-target	65
chinese	65
jnk	65
glycemia	65
association	64
gpcr	64
yeast	63
enddysf	63
causation	63
2dge	63
acid-base	63
foxo	63
me	62
smoking	62
simulation	62
avf	61
pla2	61
hsp	61
ptm	61
confounding	61
uuo	61
shc	60
sas	60
outcome	60
melamine	60
infection	60
pe	60
change	60
cost	59
eif	59
ifn	59
oral	59
llcpk1	58
crp	58
alcohol	58
mmp	58
nrk49f	57
model-selection	57
achr	57
pls	57
urate-transporter	57
pai1	57
fluorescence	57
robust	57
aceiarb	56
pdgf	56
calibration	56
hk2	56
semantic	56
competing-risk	55
goldstd	55
oglcnac	55
ratio	55
iron	54
ckd-progression	54
estrogen	54
workflow	54
stem-cell	54
function	54
bone	54
k	53
std	53
dipstick	53
renoprotection	53
qc	52
ace2	52
dimerization	52
rho	52
ncrna	52
histone	52
4ebp	51
epidemiology	51
vegf	51
normoalbuminuria	51
ab	51
fgf	51
pth	51
lod	51
cyclin-d1	51
hsc	51
atm	51
risk-ratio	50
graph	50
reasoning	50
mercury	50
arsenic	50
matlab	50
gene-environment	49
klotho	49
tf	49
epistasis	49
adpkd	49
antibiotics	49
core-curriculum	48
ngal	48
ukm	48
breakpoint	48
pld	48
ffpe	48
nrk52e	48
rapamycin	47
hdac	47
endothelium	47
spot-urine	47
joint-model	47
pooling	47
mesangial	47
p27	46
protein-microarray	46
aspirin	46
cystatin	46
translation	46
il6	46
ecm	46
fdr	46
hgf	46
dub	46
aldosterone	45
prevention	45
fgf23	45
semip	45
metal	45
wnt	45
writing	45
diuretics	44
biosensor	44
variability	44
ras	44
interaction	44
ancova	44
ccb	44
enos	43
bia	43
cnv	43
na	43
sle	43
klf	43
hepatocyte	43
design	43
ampk	43
good	42
stroke	42
bmi	42
roc	42
er-stress	42
sumo	42
agreement	42
icu	42
dbdb	42
tgfbr	41
gene-targeting	40
risk	40
hyperfiltration	40
wga	40
qtl	40
igf	40
fuzzy	40
alignment	40
irs1	39
ap1	39
dry-bw	39
urinalysis	39
asia	39
igan	38
tea	38
protein-complex	38
angiogenesis	38
sage	38
myc	38
haplotype	37
hematuria	37
animal	37
adh	37
bh4	37
rvh	37
propensity	37
mtorc1	37
fabp	37
tlr	37
emr	37
antisense	37
megalin	36
web20	36
inflammasome	36
adenosine	36
cardiorenal	36
gsk	36
catenin	36
cre	35
s100b	35
calcification	35
chemogenomics	35
subgroup	35
adduct	35
proteasome	35
omics	35
candidate-gene	35
annotation	35
threshold	35
reverse-epidemiology	35
nephrotoxicity	34
cross-species	34
effect-size	34
sepsis	34
vsmc	34
attrition	34
coffee	34
pathology	34
exercise	34
msm	34
cage	33
zeb	33
fibronectin	33
ecology	33
ns	33
rca	33
sarcopenia	33
integrin	33
snx	33
sp1	33
browser	32
zfn	32
affy	32
addgene	32
text-mining	32
end-point	32
il1	32
orbitrap	32
transactivation	31
fc	31
frailty	31
silac	31
et	31
steroid	31
hospitalization	31
heritability	31
rsk	31
risk-difference	31
blast	31
rtk	31
family	31
set	31
abp	31
gllamm	31
macrophage	31
emsa	31
mw	30
knockout	30
carcinogen	30
notch	30
bmp	30
transporter	30
membrane-protein	30
reporter	30
creb	30
staging	30
ub-ligase	29
pka	29
s100	29
extraction	29
nutrient	29
perindopril	29
nicotinic	29
ai	29
validation	29
grn	29
3	29
virus	29
pdk	29
time-dependent	28
acetylation	28
geo	28
scaling	28
mutagenesis	28
race	28
mtorc2	28
gee	28
human	27
ck2	27
pdz	27
spla2	27
cr	27
ndrd	27
thesis	27
muscarinic	27
thp	27
classification	27
cari	27
ce	27
mendelian	27
hyaluronan	26
peptide-microarray	26
agt	26
hplc	26

guhjy's aask [16 articles] Export

guhjy's tags